Suchergebnisse - "Tasnády, Szabolcs"

PubPharm (19)

1

Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients : initial case studies and literature review

enthalten in: GeroScience | 2024

von Gopcsa, L. | Réti, M. | Andrikovics, H. | +22

2

IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma

enthalten in: Cancers | 2024

von Bors, A. | Kozma, A. | Tomán, �. | +7

3

Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment : A Pilot Investigational Study

enthalten in: Journal of clinical medicine | 2023

von Szabó, B. | Reményi, P. | Tasnády, S. | +10

4

Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review

enthalten in: Age | 2023

von Gopcsa, L. | Réti, M. | Andrikovics, H. | +22

5

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19 : Two Cases

enthalten in: EJIFCC | 2022

von Papp, E. | Tasnády, S. | Tisza, K. | +2

6

Non-malignant, non-infectious lymphoproliferation : challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

enthalten in: Orvosi hetilap | 2022

von Molnár, E. | Kovács, G. | Varga, L. | +7

7

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency

enthalten in: Frontiers in immunology | 2022

von Goda, V. | Kriván, G. | Kulcsár, A. | +9

8

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

CommentIn: Geroscience. 2022 Feb;44(1):57-61. - PMID 34935099

9

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

10

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5